Health News

Intellect Neurosciences, Inc a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has received a Notice of Allowance from the United States Patent and Trademark Office related to RV01 and RV02, the Company’s two lead vaccine candidates. The Notice of Allowance is a written communication stating that the patent application has been allowed and will be granted as a new patent. RV01 and RV02, generated using the Company’s RECALL-VAX technology, have the potential to delay the onset of or prevent Alzheimer’s disease in individuals susceptible by age, genetic or other risk factor.

Read more

Filed under: Pharmacy News
Tags: Genetic, Pharmacy

Related posts

• Warning From AMP About Direct Access Genetic Testing (0)
  In response to recent announcements about consumer genetic tests being made available in retail drugstores, the Association for Molecular Pathology (AMP) today reiterated its position that these tests should be provided to the public only through the services of appropriate health care professionals that order tests from laboratories that are certified by CLIA for highcomplexity [...]
  
  
• WARFARIN study to explore impact of genetic testing on individualized dosing (0)
  Iverson Genetic Diagnostics, Inc. announced today that the WARFARIN Study was initiated in major hospital systems nationwide to assess the utility of genetic testing to determine a personalized warfarin dose for individual patients to reduce their risk of serious bleeding or clotting events. Read more [tags] Pharmacy News [/tags]
  
  
• Walgreens Shelves OTC Genetic Tests (0)
  Pharmacy giant Walgreens has decided to hold off on selling Pathway Genomics' home genetic testing kit after the FDA sent the kit manufacturer a letter warning that the tests were not federally approved. Read more [tags] General Health News [/tags]
  
  
• VUMC doctors to begin statin drug screening for rare genetic variation (0)
  Vanderbilt University Medical Center doctors announced today they will begin screening patients who take commonly prescribed statin drugs for a rare genetic variation that can increase risks for side effects from these drugs such as muscle aches, kidney damage and even death. Read more [tags] Pharmacy News [/tags]
  
  
• Viral Genetics: Company update (0)
  Our mission is to bring new drug compounds to the marketplace. And we've never been in a stronger position to deliver on that promise. We've built the solid foundation needed to take drug therapies from the laboratory to the marketplace. After years in development, we believe several of our most promising compounds are moving closer [...]